The aim of the present study is to determine if a regular oral supplementation of xanthohumol attenuate the severity of symptoms and duration of´viral infections.
In this placebo-controlled study, blood is taken on the first day of the study, followed by a 90-day intervention with xanthohumol or a placebo, which is taken twice daily. Blood samples will be taken on day 0, day 45 and day 90. Should the study participants develop a respiratory infection during the study, they will be asked to perform a self-test.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
100
Participants consume twice per day a study drink which contains 0,75 mg soluble Xanthohumol for 90 days
Participants consume twice per day a study drink which contains 0 mg soluble Xanthohumol for 90 days
University of Vienna
Vienna, Austria
RECRUITINGChanges in severity and duration of viral infections
Changes in score of Wisconsin Upper Respiratory Symptom Survey
Time frame: 90 days
Changes in blood lipid levels
Changes in triglyceride levels (mg/dl) and cholesterol levels (mg/dl)
Time frame: 90 days
Changes in cognitive skills
Assessment of cognitive processes using stroop test
Time frame: 90 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.